Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 23.39
-2.74 %
$ 1.08 B
Market Cap
-10.88
P/E
PCRX - STOCK-BASED COMPENSATION
Stock-based Compensation PCRX - Pacira BioSciences, Inc.
47.9 M
LAST VALUE
6.48%
2 YEAR CAGR
8.59%
5 YEAR CAGR
15.32%
10 YEAR CAGR